Semaglutide did not increase the risk of depression, suicidal thoughts or suicidal behavior in people without known mental ...

A total of 77 suicide deaths in GLP-1 agonist users and 71 in SGLT2 inhibitor users were identified. Subgroup analyses ...

Reuters Health Information, July 19, 2024 ADA 2024 As GLP-1 Demand Goes ... analysis didn't show a mental health benefit for bariatric surgery but that is likely due to study design, researchers ...

At least two in five U.S. adults under the age of 65 with "private insurance could be eligible under clinical criteria for GLP-1 drugs," a new KFF analysis shows.

Your one-stop shop for all the latest corporate results of South Africa’s major companies. After 64 months of market share ...

However it is an oral version of the drug which could be a landmark product, bypassing patients’ reluctance to use injections, which currently holds back uptake of GLP-1 drugs. The biggest ...

All doses of Novo Nordisk’s Ozempic are expected to face “intermittent shortages” in Europe during the fourth quarter of the ...

If you’ve found yourself unexpectedly humming the tune “Magic” lately, you’re not alone. Thanks to the catchy commercial for ...

A research group led by Prof. Zhu Yingjie from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of ...

Like its U.S. and European counterparts, Britain’s Medicines and Healthcare Products Regulatory Agency found no conclusive ...

Aspen Pharmacare fell short of its targeted mid-single digit growth in core profit on Tuesday, but is betting on GLP-1 drug ...

Liraglutide vs placebo reduced shrinking in the parts of the brain responsible for memory, learning, language, and decision-making by 50%.